TABLE A1.
Patient Characteristics by Cohort, Comparing Those in the Group Providing Baseline and At Least One Postbaseline PRO-CTCAE Report During Neoadjuvant Therapy, Those in the Subgroup Reporting Additional Patient-Reported Outcomes (HRQL cohort), and Those in the Overall Trial Population for the Analysis of Clinical End Points